Results 201 to 210 of about 21,386,765 (335)

Trends in Dermatopolymyositis Mortality, 1999–2022: A Nationwide Population‐Based Study, United States

open access: yesArthritis Care &Research, EarlyView.
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley   +1 more source

Editorial: Highlights in General Cardiovascular Medicine: 2021

open access: yesFrontiers in Cardiovascular Medicine, 2022
Lijun Wang   +5 more
doaj   +1 more source

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang   +4 more
wiley   +1 more source

Burden of cardiovascular disease in China attributable to unbalanced fatty acid intake from 1990 to 2050. [PDF]

open access: yesAsia Pac J Clin Nutr
Liu X   +7 more
europepmc   +1 more source

Editorial, v. 25, n. esp. 2, maio 2021

open access: diamond, 2021
Sebastião de Souza Lemes   +2 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy